Navigation Links
Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
Date:8/13/2012

SAN DIEGO, Aug. 13, 2012 /PRNewswire/ -- Elcelyx Therapeutics announced today that Mark Wiggins has joined the company as Senior Vice President of Business Development and Ginger Graham has been elected to the Board of Directors. Elcelyx is developing ultra-safe first-in-class approaches to weight management and obesity-related metabolic disorders.

"In two short years, Elcelyx has amassed proof of concept and efficacy data for two product candidates for weight loss, Type 2 diabetes and other obesity-related metabolic disorders. Mark joins us as we accelerate our late-stage programs to value-creating inflection points that will be attractive to strategic partners in the nutrition and pharmaceutical industries," said Alain Baron, M.D., President and Chief Executive Officer of Elcelyx Therapeutics.  "Ginger has worked closely with several members of the Elcelyx team over the years, and her extensive expertise in both the consumer and pharmaceutical health sectors will be valuable as we execute our strategies to address the rising rates of obesity and metabolic disorders across the globe."

Wiggins was most recently Chief Business Officer at Mpex Pharmaceuticals, where he led commercial planning and business development for the company's inhaled antibiotics unit until the company was acquired by Axcan in 2011. Prior to joining Mpex, he served as Executive Vice President of Business Development and was a member of the Executive Committee of Biogen Idec. During his 11 years at Biogen Idec and its predecessor Idec Pharmaceuticals, Wiggins was involved in a wide variety of commercial and business development activities and was a member of the management committee for the collaboration with Genentech on blockbuster Rituxan®, which is used for treating a number of cancer and autoimmune indications. He and his team completed three acquisitions and more than 20 licensing/partnering transactions. Prior
'/>"/>

SOURCE Elcelyx Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics Announces Second Quarter 2012 Financial Results
2. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
3. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
4. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
5. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
6. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
7. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
8. Silence Therapeutics - Admission of Shares and Board Update
9. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
10. OrPro Therapeutics Receives NIH Grant Award to Advance Development of Recombinant Thioredoxin for Treatment of Cystic Fibrosis
11. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Una presentazione speciale durante la settimana della ... di MERG valutare i successi ottenuti grazie ... svariate popolazioni di pazienti affetti dalla patologia. ... Ronnie Fass , MD della Case Western Reserve University, ... relativi alla terapia Stretta. Un panel di esperti ha ...
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... VILLAGE, Nev. , May 27, 2015  PDL ... that John P. McLaughlin , the company,s president ... 2015 Global Healthcare Conference next week in New York ... on Wednesday, June 3, 2015 at 11:30 a.m. EDT. ... webcast of the presentation, go to the Company,s website ...
Breaking Medicine Technology:Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... , SAN CARLOS, Calif., Nov. 30 ... promotion of Lorianne Masuoka, M.D. to Senior Vice President ... directly to Nektar,s President and Chief Executive Officer, Howard ... highly effective clinical development strategies have been instrumental in ...
... , CHICAGO, Nov. 30 Breast-Specific Gamma Imaging ... high-risk lesions in patients with negative or indeterminate mammographic ... today at the annual meeting of the Radiological Society ... BSGI was conducted as an adjunct diagnostic imaging modality ...
Cached Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2
(Date:5/27/2015)... Valley, CA (PRWEB) May 27, 2015 For ... Dr. Peyman Ghasri, is now offering discounts on facial fillers. ... year after the age of 18. This lost collagen can ... sunken cheeks, wrinkles and expression lines. Facial fillers are an ... Many people turn to facial fillers to create a softer ...
(Date:5/27/2015)... 27, 2015 Decorview , a ... is offering free design advice to homeowners looking to ... , “Light pollution caused by streetlights, outdoor signs, full ... night’s sleep, said Kim Rush, VP of sales and ... across North America with recently installed LED streetlights– the ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
(Date:5/27/2015)... May 27, 2015 Altec Products, Inc., ... announced today their Premier Sponsorship of Connections 2015. The ... Hilton on Thursday, May 28th and will deliver to ... well as the roadmap to get there. , ... in the sale, installation and support of Intacct Cloud ...
(Date:5/27/2015)... 27, 2015 With the FCPX LUT ... can quickly and easily add filmic color grades to their ... files. , FCPX LUT Cross Processed Plugin can instantly make ... looks and everything in between. , FCPX LUT Cross Processed ... in many different softwares. With the FCPX LUT Cross Processed ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:CRN International Names New Chief Financial Officer 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2
... ABT ),will present at the Citi Investment Research ... C. Freyman, executive vice president,finance and chief financial officer, ... Central time., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... With the economy tight and,sales forces shrinking across ... maintain an effective sales force. Regardless, a company,s ... success going forward. That,success is predicated on establishing ... goals and managing groups in a way,that meets ...
... increase the risk of Alzheimers Disease by as much as ... issue of Obesity Reviews. , But its not just weight ... have an elevated risk of dementia, unlike people who are ... detailed review of 10 international studies published since 1995, covering ...
... staffing company to launch nationally-syndicated television ... ... Access,Nurses announced today a national campaign to change the image of nursing,in ... lives of nurses working on the front lines of modern,healthcare. The show, ...
... May 7 Emageon Inc. (Nasdaq:,EMAG), a leader in ... imaging facilities, will hold its,quarterly conference call to discuss ... at 10:00 AM Eastern Time. The company anticipates,that these ... the NASDAQ,stock market opens on May 12, 2008., ...
... May 7 AMDL, Inc. (Amex: ... in Shenzhen, Jiangxi,and Jilin, China, is a ... its subsidiary Jade Pharmaceutical Inc. (JPI),the Company ... of diagnostic, pharmaceutical, nutritional supplement, and,cosmetic products., ...
Cached Medicine News:Health News:Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies 2Health News:Obesity can increase dementia risk by up to 80 percent 2Health News:Nursing Shortage Spurs Campaign to Change the Image of Nursing in the Media 2Health News:Emageon Inc. to Host First Quarter 2008 Financial Results Conference Call May 12, 2008 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 2Health News:AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: